Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hersch

Showing results (101-110 of 129) with videos related to

Pageof 13
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 17, 2003
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease miceRobert J Ferrante, James K Kubilus, Junghee Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1993
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodiesA I Levey, S M Hersch, D B Rye, et al.
Chemistry & Biology|July 29, 2006
Discovery of bioactive small-molecule inhibitor of poly adp-ribose polymerase: implications for energy-deficient cellsStephen M Altmann, Andrey Muryshev, Elisa Fossale, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouseYi Hu, Vanita Chopra, Raman Chopra, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2000
Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathologyT B Freeman, F Cicchetti, R A Hauser, et al.
Neuroimage|October 24, 2009
Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection"H Diana Rosas, Stephanie Y Lee, Alexander C Bender, et al.
The Journal of Biological Chemistry|April 6, 2006
Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotectiveZhihua Qiu, Fran Norflus, Bhupinder Singh, et al.
Biochimica Et Biophysica Acta|May 13, 2010
Reduced creatine kinase as a central and peripheral biomarker in Huntington's diseaseJinho Kim, Daniel J Amante, Jennifer P Moody, et al.
Cell|December 31, 1997
Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouseJ M Ordway, S Tallaksen-Greene, C A Gutekunst, et al.
Neurobiology of Disease|July 13, 2001
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's diseaseO A Andreassen, A Dedeoglu, R J Ferrante, et al.
Pageof 13

Showing results (101-110 of 129) with videos related to

Sort By:
Pageof 13
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 17, 2003
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease miceRobert J Ferrante, James K Kubilus, Junghee Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1993
Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodiesA I Levey, S M Hersch, D B Rye, et al.
Chemistry & Biology|July 29, 2006
Discovery of bioactive small-molecule inhibitor of poly adp-ribose polymerase: implications for energy-deficient cellsStephen M Altmann, Andrey Muryshev, Elisa Fossale, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 5, 2011
Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouseYi Hu, Vanita Chopra, Raman Chopra, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2000
Transplanted fetal striatum in Huntington's disease: phenotypic development and lack of pathologyT B Freeman, F Cicchetti, R A Hauser, et al.
Neuroimage|October 24, 2009
Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical "disconnection"H Diana Rosas, Stephanie Y Lee, Alexander C Bender, et al.
The Journal of Biological Chemistry|April 6, 2006
Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotectiveZhihua Qiu, Fran Norflus, Bhupinder Singh, et al.
Biochimica Et Biophysica Acta|May 13, 2010
Reduced creatine kinase as a central and peripheral biomarker in Huntington's diseaseJinho Kim, Daniel J Amante, Jennifer P Moody, et al.
Cell|December 31, 1997
Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouseJ M Ordway, S Tallaksen-Greene, C A Gutekunst, et al.
Neurobiology of Disease|July 13, 2001
Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's diseaseO A Andreassen, A Dedeoglu, R J Ferrante, et al.
Pageof 13